Form 4: MAIA Biotechnology Director Ramiro Guerrero Acquires Stock Options

Director Ramiro Guerrero acquired 9,193 stock options in MAIA Biotechnology, Inc. on March 31, 2024.

Summary

• Ramiro Guerrero, a director of MAIA Biotechnology, Inc., filed a Form 4 on April 2, 2024, reporting a transaction.
• On March 31, 2024, Guerrero acquired 9,193 stock options at a price of $2.20.
• These options, granted under the company's 2021 Equity Incentive Plan, vest immediately and are exercisable from the grant date.
• The options represent the right to buy 9,193 shares of MAIA Biotechnology's common stock.
• Following the transaction, Guerrero directly owns 9,193 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Immediate vesting and exercisability of the options may incentivize the director to work towards the company's success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders.

Stakeholder Impact

• The grant of stock options to a director can align their interests with those of the shareholders, potentially benefiting shareholders.

Key Dates